Form 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the month of July 2008

Commission File Number: 001-31368

SANOFI-AVENTIS

(Translation of registrant’s name into English)

174, avenue de France, 75013 Paris, FRANCE

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x                    Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):             

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):             

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨                                            No x

If “Yes” marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-                

 

In July 2008, sanofi-aventis issued the press releases attached hereto as Exhibits 99.1, 99.2, 99.3 and 99.4 which are incorporated herein by reference.

Exhibit List

 

Exhibit No.

   

Description

Exhibit 99.1    Press release dated July 21, 2008: Sanofi-aventis enters into agreement with Primary Health Care to acquire “Symbion Consumer” in Australia.
Exhibit 99.2    Press release dated July 25, 2008: Recommended Offer by Sanofi Pasteur for Acambis plc.
Exhibit 99.3    Press release dated July 29, 2008: Clopidogrel in Germany.
Exhibit 99.4    Press release dated July 31, 2008: Half Year Results Announcement

 

 

 

 

 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: July 31, 2008     SANOFI-AVENTIS
    By  

              /S/    Karen Linehan

      Name:   Karen Linehan
      Title:  

Senior Vice President

Legal Affairs and General Counsel

 

 

 

 

 

3

Exhibit Index

 

Exhibit No.

   

Description

Exhibit 99.1

    Press release dated July 21, 2008: Sanofi-aventis enters into agreement with Primary Health Care to acquire “Symbion Consumer” in Australia.

Exhibit 99.2

    Press release dated July 25, 2008: Recommended Offer by Sanofi Pasteur for Acambis plc.

Exhibit 99.3

    Press release dated July 29, 2008: Clopidogrel in Germany.

Exhibit 99.4

    Press release dated July 31, 2008: Half Year Results Announcement

 

 

 

 

4